![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
CRH Plc | TG:CRG | Tradegate | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.46 | 0.68% | 68.42 | 67.88 | 68.42 | 68.42 | 68.28 | 68.28 | 237 | 10:54:10 |
RNS Number:6669S Corin Group PLC 01 December 2003 Corin Group PLC UPDATE ON US METAL-ON-METAL REGULATORY STATUS As reported in the interim statement dated 23 September 2003, Corin has been in discussions with the FDA concerning the appropriate approval route for its large diameter stemmed metal-on-metal hip in the US. The FDA has advised Corin that the Group will need to provide US-generated clinical data. Accordingly, Corin is now seeking FDA approval to run a full US-based clinical trial, which is expected to commence in the first quarter of 2004. The US clinical trial for Corin's metal-on-metal resurfacing device, Cormet, remains on schedule, with full approval expected to be granted in 2006. 1 December 2003 Enquiries: Corin Group PLC Ian Paling, Chief Executive Tel: 01285 659 866 Simon Hartley, Finance Director College Hill Tel: 020 7457 2020 Adrian Duffield/Clare Warren This information is provided by RNS The company news service from the London Stock Exchange END MSCFSISUFSDSESE
1 Year CRH Chart |
1 Month CRH Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions